Viral-mediated fusion of mesenchymal stem cells with cells of the infarcted heart hinders healing via decreased vascularization and immune modulation

Cell fusion can occur between mesenchymal stem cells (MSCs) transplanted to improve cardiac function and cells of the recipient. The therapeutic benefit or detriment of resultant cell hybrids is unknown. Here we augment fusion of transplanted MSCs with recipient cardiac cell types via viral fusogens...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Brian T., Ogle, Brenda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742880/
https://www.ncbi.nlm.nih.gov/pubmed/26846200
http://dx.doi.org/10.1038/srep20283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742880/
https://www.ncbi.nlm.nih.gov/pubmed/26846200
http://dx.doi.org/10.1038/srep20283

Ejemplares similares